For the first time, a major scientific study has confirmed what cannabis advocates have known for decades: that cannabis can be a safe and effective palliative treatment in patients suffering from the debilitating effects of cancer.
Through a partnership with a MyDx licensee, they are aiming to provide cannabis patients and consumers with the world's most comprehensive database about the products they are consuming.
Nearly 63% of patients also reported reduced or eliminated opioid usage after six months of using medical cannabis.
Around one third of patients treated for epilepsy continue to have seizures, this study finds that CBD could help.
The Cannabis Science, Dana-Farber research team has now begun next level planning to bring this efficacious research to full commercialization.
A new study suggests that smoking cannabis may lower the number of prescription opioids needed to produce pain relief.
In a unique and potentially transformative drug delivery technique, PreveCeutical Medical is engineering the world's first nose-to-brain drug delivery platform.
Here we look at some of the key differences, and similarities, between the most well-known cannabinoids, CBD and THC.
As cannabis has anti-inflammatory properties there may be potential for topical cannabis to improve conditions such as acne, psoriasis and eczema by reducing the inflammation associated with these diseases.
Guidelines warn health risks may outweigh benefits but in reality clinical evidence to support claims either way is lacking.